“The National Recovery and Resilience Plan (PNRR) highlights the need to focus on
local medicine, but it becomes necessary to ensure governance by
laboratory professionals to ensure the reliability of the results wherever they are
carried out ”. This is what Laura Sciacovelli, National President of the Company, said
Italian Clinical Biochemistry and Clinical Molecular Biology (SIBioC) during a live broadcast
Facebook organized today by the Scientific Society. Thanks to scientific progress and the
development of new technologies and methodologies that have made it possible to perform millions of
exams every year, laboratory medicine has undergone a strong evolution and
transformation. The Covid emergency has highlighted the central role of laboratories
of analysis and great effort was required of laboratory specialists, not only for
the execution of a very high number of tests to diagnose the disease but also for
validate the analytical systems that have been placed on the market.
“Scientific research is leading more and more towards personalized medicine and
precision in many branches of medicine such as, for example, oncology, neurology or
rheumatology where pharmacological therapies are gaining ground in clinical practice
extremely effective. “One of our primary goals is to ensure appropriateness
diagnostics and therapy through the laboratory tests we carry out
daily and active participation in clinical teams for the definition of the Pathways
diagnostic therapeutic assistance (PTDA) in the various specialist fields. Therefore it becomes
It is essential to invest in laboratory medicine because it is extremely important
guarantee the best state of health for the patient and the citizen ”, underlined Sciacovelli.
Furthermore, in full awareness of the role that Laboratory Medicine has in
company, SIBioC pays great attention to young professionals – the presence of Dr.ssa
Claudia Bellini in the direct Facebook is the expression of this will. Projects by
training and skills development, especially aimed at young professionals,
and the disclosure of authoritative consent documents are the tools that SIBioC uses
available for a future based on quality and preparation, fundamental elements for the
progress in the health sector and in the country.
.